Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the Anti-Inflammation Effects of Pioglitazone,
twice daily (BID), and Pioglitazone/Metformin Combination Therapy BID in Type 2 Diabetes
Subjects Treated with Insulin.